BGIN BLOCKCHAIN LIMITED Announces Resolution of Subsidiary’s Hosting Dispute and Full Recovery of Mining MachinesSINGAPORE, April 13, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (the “Company”; NASDAQ: BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and a manufacturer of cryptocurrency mining hardware, today announced the successful resolution of a series of disputes involving its US subsidiary, BGIN Infrastructure, LLC (“BGIN”), and Mawson Hosting, LLC (“Mawson”), the landlord of BGIN’s former hosting service provider, Krypton Technologies, LLC (“Krypton”). As part of a confidential settlement agreement BGIN has recovered all of its mining machines.
Vitaquest Fall 2026 Dietary Supplement Trends Report: Key Insights for Brands and ManufacturersNew report highlights women’s health, longevity, energy, gut health, and cognitive wellness as leading categories shaping product innovation and consumer demand
ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA DeviceSAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG (FDA K252765). The RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision oral appliance therapy and multi-night physiologic monitoring in one device.
Springboards Launches ‘Flint’ to Break AI’s Habit of Predictable, Boring AnswersThe world’s first divergence model expands the creative idea space by maximising the variance of every response
Beyond Meat® Debuts Latest Beyond Breakfast Sausage® Lineup at Retailers Nationwide Including Kroger, Sprouts Farmers Market and Whole Foods MarketNew Beyond Breakfast Sausage Links and Patties, now made with heart-healthy avocado oil,1 deliver craveable taste, clean ingredients and strong nutrition
Leishen Energy Reaffirms Middle East Market Commitment; Saudi Production Facility Progressing Amid Regional ChallengesRIYADH, Saudi Arabia, April 13, 2026 (GLOBE NEWSWIRE) -- Leishen Energy Holding Co., Ltd. ("Leishen Energy" or the "Company") (
NASDAQ: LSE), a leading provider of clean-energy equipment and integrated solutions for the oil and gas industry, today reaffirmed its long-term strategic commitment to the Middle East market, confirming that the development of its Saudi Arabia production facility, LSE Energy International, continues to advance as planned, notwithstanding ongoing regional conflicts.
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cowsWith the launch of LENZELTA®, Boehringer Ingelheim enhances its comprehensive mastitis portfolio, offering farmers and veterinarians effective solutions to keep their dairy cattle healthy and farms viable. The vaccine will be available in several countries in the European Union (EU) as of April 2026.
FTI Consulting Appoints Benedict Brogan to Strategic Communications SegmentLONDON, April 13, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (
NYSE: FCN) today announced the appointment of Benedict Brogan as a Senior Managing Director within the firm’s Strategic Communications segment.
Baker Hughes Announces Sale of Waygate Technologies to HexagonHOUSTON and LONDON, April 13, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR, “the Company”), an energy technology company, announced Monday that it has entered into an agreement to sell its Waygate Technologies business to Hexagon, a global leader in measurement technologies. The all-cash transaction is valued at approximately $1.45 billion, before customary closing adjustments.
CORRECTION - Israel Tech Week Moves Forward in Miami Amid Ongoing War in IsraelThe conference is one of the year’s few in-person platforms for Israeli innovation to connect directly with global investors and partners
WISeSat and Swiss Space Command of the Swiss Armed Forces Complete Pilot Phase and Prepare Next-Generation WISeSat 6U Mission Planned for November 2026WISeSat and Swiss Space Command of the Swiss Armed Forces Complete Pilot Phase and Prepare Next-Generation WISeSat 6U Mission Planned for November 2026
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduced urticaria activity compared with placebo in adults
Rubicon Organics Launches 1964 Supply Co.™ in the U.K.Company launches 1964 Supply Co.™ medical cannabis products in the U.K. through a distribution partnership with 4C LABS
Bragar Eagel & Squire, P.C. Reminds Eos Energy Enterprises, Inc. (NASDAQ: EOSE) Investors to Contact the Firm Regarding Their Rights Before May 6thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Eos (EOSE) To Contact Him Directly To Discuss Their Options
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial CancerMAINZ, Germany, April 11, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced positive results from the primary analysis of a Phase 2 cohort evaluating trastuzumab pamirtecan (BNT323/DB-1303) in patients with HER2-expressing, advanced endometrial cancer whose disease progressed on or after first-line chemotherapy with or without prior checkpoint inhibitor treatment. This cohort is part of a global Phase 1/2a clinical trial (NCT05150691) investigating the HER2-targeted antibody-drug conjugate (“ADC”) candidate trastuzumab pamirtecan in multiple solid tumors.
Alleron Expert Group Marks Six Years of 100% Client Retention, Announces Expanded Cloud Services PortfolioBoston-Based Firm Challenges Industry Status Quo with Senior-Only Engineering Model and Financially Guaranteed Uptime
Bunker Hill Announces Equity Compensation GrantsKELLOGG, Idaho and VANCOUVER, British Columbia, April 10, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR) (OTCQB: BHLL) announces that its board of directors (the “Board”) has approved the grant of an aggregate of 163,674 restricted stock units (the “RSUs”) to certain directors and officers of the Company pursuant to the terms of the Company’s amended and restated restricted stock unit incentive plan (the “RSU Plan”). The RSUs will vest in one-third increments on April 10, 2027, April 10, 2028, and April 10, 2029, with each RSU vesting into one share of common stock of the Company (a “Common Share”) at a deemed price of C$5.60 based on the closing price of the Common Shares on the Toronto Stock Exchange (the “TSX”) on April 9, 2026.
Innovator Announces Results of Special Meeting of Shareholders Relating to the Reorganizations of Innovator IBD® Breakout Opportunities ETF and Innovator IBD® 50 ETFWHEATON, Ill., April 10, 2026 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (“Innovator”) announced today the results of the joint special meeting of shareholders of Innovator IBD® Breakout Opportunities ETF (NYSE Arca: BOUT) and Innovator IBD® 50 ETF (NYSE Arca: FFTY) (each a “Target Fund” and collectively, the “Target Funds”) held of April 10, 2026.
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced MelanomaWOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (
NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for the Company’s Biologics License Application (BLA) for RP1 in combination with nivolumab for the treatment of advanced melanoma.
TC Energy to host first quarter 2026 conference call on May 1 and hold annual meeting of common shareholders on May 7CALGARY, Alberta, April 10, 2026 (GLOBE NEWSWIRE) -- TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will hold a teleconference and webcast on Friday, May 1, 2026 to discuss its first quarter financial results, and hold its 2026 annual meeting of common shareholders on Thursday, May 7, 2026.
UPDATE -- Aeroméxico Announces Webcast of First Quarter 2026 Financial ResultsMEXICO CITY, April 10, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) will hold a live conference call and webcast on Wednesday, April 22, 2026, at 10:30 a.m. Mexico City Time (12:30 p.m. Eastern Time) to discuss its first quarter 2026 financial results.
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on April 8, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 258,200 shares of Class A common stock and restricted stock units (RSUs) underlying 131,925 shares of Class A common stock to eighty-nine (89) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
Hub Group (NASDAQ: HUBG) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a top complex litigation law firm, is investigating Hub Group Inc. (
NASDAQ: HUBG) (“Hub Group” or the “Company”) for potential violations of the federal securities laws.
Artisan Partners Asset Management Inc. Reports March 2026 Assets Under ManagementMILWAUKEE, April 10, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (
NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of March 31, 2026 totaled $173.0 billion. Artisan Funds and Artisan Global Funds accounted for $84.5 billion of total firm AUM, while separate accounts and other AUM1 accounted for $88.5 billion.
Coca-Cola Consolidated, Inc. Announces Second Quarter DividendCHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (
NASDAQ: COKE) announced that its Board of Directors has declared a dividend for the second quarter of 2026 of $0.25 per share on shares of the Company's Common Stock and Class B Common Stock payable on May 8, 2026, to stockholders of record as of the close of business on April 24, 2026.
Proficient Auto Logistics Sets Date to Report First Quarter 2026 Financial ResultsJACKSONVILLE, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (
NASDAQ: PAL) (the “Company”) announced that the Company will host an investor conference call at 5:00 p.m. EDT on Thursday, May 7, 2026, to discuss its operating and financial results for the three months ended March 31, 2026. A press release disclosing those results will be issued at approximately 4:00 p.m. EDT on that day.
Main Street Financial Services Corp. Declares Quarterly DividendWOOSTER, Ohio, April 10, 2026 (GLOBE NEWSWIRE) -- Main Street Financial Services Corp. (OTCQX:MSWV), (the “Company”), the holding company parent of Main Street Bank Corp. (the “Bank") has declared a cash dividend of $0.15 per share of the Company’s common stock for the quarter ending March 31, 2026. The quarterly cash dividend will be paid on May 8, 2026 to stockholders of record as of April 27, 2026.
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026WALTHAM, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (
NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases, today announced it will report SPY001 Part A induction topline results from the SKYLINE trial in moderate-to-severely active ulcerative colitis patients on Monday, April 13, 2026. Following the announcement, the Company will host a conference call and webcast at 8:00am ET on Monday April 13, 2026 to discuss the results.
Robin Energy Ltd. Announces Availability of its 2025 Annual Report on Form 20-FLIMASSOL, Cyprus, April 10, 2026 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (
NASDAQ: RBNE), (“Robin Energy” or the “Company”), an international ship-owning company providing energy transportation services globally, announces that the Company’s annual report on Form 20‐F (the “Annual Report”), which contains the Company’s financial statements for the fiscal year ended December 31, 2025, was filed with the U.S. Securities and Exchange Commission (the “SEC”).
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026SOUTH SAN FRANCISCO, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced the Company will host a conference call and webcast to review the interim futility analysis from its pivotal, randomized Phase 2 ALPHA3 trial with cemacabtagene ansegedleucel (cema-cel) in first-line (1L) consolidation large B-cell lymphoma (LBCL) on Monday, April 13, 2026.
Remitly Appoints Technology Veteran Adam Messinger to its Board of DirectorsSEATTLE, April 10, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (
NASDAQ: RELY) (“Remitly”) today announced the appointment of Adam Messinger to its Board of Directors (the “Board”). With this appointment, Remitly is increasing the size of its Board from 10 to 11 directors. In connection with his appointment, Mr. Messinger also joins the Talent and Compensation Committee of the Board.
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a top complex litigation law firm, is investigating ADMA Biologics (
NASDAQ: ADMA) (“ADMA Biologics” or the “Company”) for potential violations of the federal securities laws.
NUAI Investors Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against New Era Energy & Digital, Inc. (“New Era” or “the Company”) (
NASDAQ: NUAI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (
NASDAQ: GOSS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” or “the Company”) (
NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
National Association of REALTORS® Reaches Agreement to Resolve Nationwide Homebuyer Claims in Tuccori v. At World PropertiesSettlement in Tuccori Litigation to Provide Broad Level of Protection and Release for Associations, Certain Brokers, and REALTOR® Members; Outcome Represents Latest Positive Legal Outcome for NAR and its Members Under New Legal Leadership Team, as the Association Continues Multi-Year Transformation
J. JILL INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating J. Jill, Inc. on Behalf of J. Jill Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In J. Jill (JILL) To Contact Him Directly To Discuss Their Options
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare ConferenceORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (
NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference.
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vital Farms, Inc. (“Vital Farms” or “the Company”) (
NASDAQ: VITL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
E.L.F. BEAUTY ALERT: Bragar Eagel & Squire, P.C. is Investigating e.l.f. Beauty, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In e.l.f. Beauty (ELF) To Contact Him Directly To Discuss Their Options
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Super Micro Computer, Inc. (“Super Micro” or “the Company”) (
NASDAQ: SMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (
NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Suja Life Announces Filing of Registration Statement for Proposed Initial Public OfferingOCEANSIDE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Suja Life, Inc. has applied to list its common stock on The Nasdaq Global Select Market under the ticker symbol "SUJA."
PINS Investors Have Opportunity to Lead Pinterest, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (
NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MOVA AtomForm Unveils 12-Nozzle Multi-Color 3D Printing System at RAPID + TCT 2026The flagship AtomForm Palette 300 eliminates filament waste through "OmniElement" technology, bridging the gap between consumer accessibility and industrial-grade efficiency
Novarad to Showcase Surgical Augmented Reality Platform VisAR at SIR 2026Live demonstrations will highlight surgical augmented reality for image-guided procedures and interventional workflows
Boys & Girls Clubs of America Names 2026 Alumni Hall of Fame InducteesLeaders Across Sports, Entertainment, Business and Media to be Honored at April 30 Ceremony in Charlotte
Origin Bancorp, Inc. Announces First Quarter 2026 Earnings Release and Conference CallRUSTON, La., April 10, 2026 (GLOBE NEWSWIRE) -- Origin Bancorp, Inc. (
NYSE: OBK) (“Origin”), the financial holding company for Origin Bank, plans to issue first quarter 2026 results after the market closes on Wednesday, April 22, 2026, and hold a conference call to discuss such results on Thursday, April 23, 2026, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time). The conference call will be hosted by Drake Mills, Chairman, President and CEO of Origin, William J. Wallace, IV, Chief Financial Officer of Origin, and Lance Hall, President and CEO of Origin Bank.
Transaction in Own SharesTransaction in Own Shares
FERRARI N.V.: COMPLETION OF THE FIRST TRANCHE AND ANNOUNCEMENT OF THE SECOND TRANCHE OF THE MULTI-YEAR SHARE REPURCHASE PROGRAMMaranello (Italy), April 10 2026 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 250 million share buyback program announced on December 16, 2025, as the first tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the “First Tranche”), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) and on the New York Stock Exchange (NYSE) as follows:
BROAD ARROW AUCTIONS TO OFFER EXTREMELY RARE GORDON MURRAY AUTOMOTIVE T.50 VIA LIVE AUCTION DURING THE CALIFORNIA MILLESpecial single-car live auction set for April 21 at the Allegretto Vineyard Resort in Paso Robles, California, a stop along the journey of the celebrated California Mille tour | The 2025 Gordon Murray Automotive T.50 on offer is one of 100 examples built of “the world’s greatest driver’s car”, in bespoke Reef finish and showing just 27 delivery miles | A portion of proceeds from the sale of the rare supercar will benefit the California Highway Patrol 11-99 Foundation and McPherson College | Learn more about the T.50 and register to bid at broadarrowauctions.com
Stylish and Elegant: Kaiyi X7 Hybrid Officially Launches in Uzbekistan, Defining Affordable LuxuryYIBIN, China, April 10, 2026 (GLOBE NEWSWIRE) -- On April 2nd, Kaiyi Auto officially launched its globally designed X7 Hybrid 7-seater SUV in Tashkent, Uzbekistan, in partnership with local dealer CMG-CAMEL AUTO. The event highlighted the model's avant-garde design, spacious interior, and intelligent hybrid capabilities, offering a compelling new option for local families. This also marks a significant step forward in Kaiyi Auto's globalization strategy in the Central Asian market.
Willow Bridge Maintains Title of 3rd Largest Multifamily Manager in 2026 NMHC Top 50 Rankings and Named a Top DeveloperWillow Bridge’s Park at Katy Trail in Dallas reflects the excellence behind its No. 3 manager and No. 20 developer rankings in the 2026 NMHC Top 50.
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Pinterest, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Pinterest (PINS) To Contact Him Directly To Discuss Their Options
IMMUNITYBIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages Immunity Bio, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their RightsBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In ImmunityBio (IBRX) To Contact Him Directly To Discuss Their Options
